Abstract
The present invention relates to short peptides based on the amino acids sequence of the N-terminal domain of the human mitochondrial protein voltage-dependent anion channel 1 (VDAC) and to peptide conjugates further comprising a cell permeability enhancing moiety. The peptides, peptide conjugates and pharmaceutical composition comprising same are useful for treating diseases characterized by cell hyperproliferation or resistance to cell death, particularly cancer.
Original language | English |
---|---|
Patent number | WO2015011711 |
IPC | C07K 19/ 00 A I |
Priority date | 25/07/13 |
State | Published - 29 Jan 2015 |